Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
July/August 2010, Vol 3, No 4
Practice Management
Accountable Care Organizations in the Era of Healthcare Reform
Read More
Practice Management
The New Accountable Care Organizations and Medicare Gain-Sharing Program
Kip Piper, MA, FACHE
Read More
Practice Management
The Impact of Healthcare Reform on Payers’ Products, Provider Reimbursement, and Member Engagement
Sam Muppalla
,
Robert Capobianco
Read More
Practice Management
Enhanced Generic Utilization Saved US Healthcare $139.6 Billion in 2009
Dalia Buffery, MA, ABD
Read More
Practice Management
The Current State of Bundled Payments
Jim Evans
Read More
Practice Management
Expect the Unexpected: A Role for Behavioral Economics in Understanding the Impact of Cost- Sharing on Emergency Department Utilization
Albert Tzeel, MD, MHSA, CPE, FAAPL
,
Jack Brown, BA
Stakeholder Perspective
by
Alberto M. Colombi, MD, MPH
Read More
Original Research
Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: Observational Study
Anna D’Souza, PhD
,
Brian L. Meissner, PharmD, PhD
,
Boxiong Tang, MD, PhD
,
Scott McKenzie, MD
,
Catherine T. Piech, MBA
Stakeholder Perspective
Effectiveness of Anti-TNFs in Patients with RA, and Coverage Considerations
by
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Practice Management
Comparing Medical Cost of Care for Patients with Metastatic Breast Cancer Receiving Taxane Therapy: Claims Analysis
Rex W. Force, PharmD
,
Brooke A. Pugmire, PharmD
,
Vaughn L. Culbertson, PharmD
Stakeholder Perspective
Can We Afford Improved Clinical Outcomes?
by
Atheer A. Kaddis, PharmD
Read More
Results 1 - 8 of 8